[ad_1] NEWTOWN, Pa., July 28, 2024 /PRNewswire/ — Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Dexcom, Inc. (NASDAQ: DXCM) resulting from allegations of providing potentially misleading business information to the investing public. […]
Trending Stories
Rosen Law Firm Encourages Allarity Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation
[ad_1] NEW YORK, July 28, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Allarity Therapeutics, Inc. (NASDAQ: ALLR) […]
MDB Investors Have Opportunity to Lead MongoDB, Inc. Securities Fraud Lawsuit
[ad_1] NEW YORK, July 28, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds investors a shareholder filed a class action lawsuit on behalf of all purchasers of securities of MongoDB, […]
Luye Pharma Announces U.S. FDA Approval of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for Treating Schizophrenia and Schizoaffective Disorder
[ad_1] PRINCETON, N.J., July 28, 2024 /PRNewswire/ — Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sales of innovative medications, today announced that the U.S. Food and Drug […]
Piramal Pharma Limited gibt konsolidierte Ergebnisse für Q1GJ25 bekannt
[ad_1] Contract Development and Manufacturing Organization (CDMO) (Vertragliche Entwicklungs- und Herstellungsorganisation) : • Erste Anzeichen für eine Belebung der Biotech-Finanzierung und eine Zunahme der Kundenanfragen und -besuche, insbesondere für differenzierte Angebote. Benötigt ein paar konsistentere Quartale, […]














